Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia Spectrum and Other Psychotic Disorders

Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.

68 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Completed

A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

NCT05227690

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Little Rock, Arkansas Little Rock, Arkansas, United States
  • Anaheim, California Anaheim, California, United States
  • Garden Grove, California Garden Grove, California, United States
  • Lemon Grove, California Lemon Grove, California, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

NCT05443724

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Phoenix, Arizona Phoenix, Arizona, United States
  • Bryant, Arkansas Bryant, Arkansas, United States
  • Little Rock, Arkansas Little Rock, Arkansas, United States
  • Anaheim, California Anaheim, California, United States
View all 85 locations
View Trial Details
Completed

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

NCT05321602

Conditions
Antipsychotic Agents, Central Nervous System Depression, Mental Disorders, +9 more
Locations
  • Woodland International Research Group Little Rock, Arkansas, United States
  • CNS Research Garden Grove, California, United States
  • NRC Research Institute Orange, California, United States
  • Collaborative Neuroscience Network, LLC Torrance, California, United States
View Trial Details

Related conditions